PMV Pharmaceuticals Inc

General ticker "PMVP" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $81.6M

PMV Pharmaceuticals Inc does not follow the US Stock Market performance with the rate: -17.1%.

Estimated limits based on current volatility of 2.5%: low 1.44$, high 1.51$

Factors to consider:

  • Current price 14.8% below estimated low
  • Earnings for 9 months up through Q3 exceed our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2023-12-31 to 2025-12-30

  • 2023-12-31 to 2024-12-30 estimated range: [1.77$, 4.95$]
  • 2024-12-30 to 2025-12-30 estimated range: [2.28$, 5.76$]

Financial Metrics affecting the PMVP estimates:

  • Negative: Non-GAAP EPS, $ of -1.45 <= 0.10
  • Negative: Operating profit margin, % of -100 <= 1.03
  • Negative: Operating cash flow per share per price, % of -32.81 <= 2.35
  • Negative: negative Net income
  • Positive: Industry inventory ratio change (median), % of 0 <= 0
  • Positive: Interest expense per share, $ of 0 <= 0

Similar symbols

Short-term PMVP quotes

Long-term PMVP plot with estimates

Financial data

YTD 2021-12-31 2022-12-31 2023-12-31
Operating Revenue $0.00MM $0.00MM $0.00MM
Operating Expenses $58.29MM $77.04MM $80.13MM
Operating Income $-58.29MM $-77.04MM $-80.13MM
Non-Operating Income $0.47MM $3.71MM $11.17MM
R&D Expense $36.49MM $51.99MM $55.88MM
Income(Loss) $-57.82MM $-73.33MM $-68.96MM
Taxes $0.02MM $-0.01MM $0.00MM
Profit(Loss) $-57.85MM $-73.32MM $-68.96MM
Stockholders Equity $308.56MM $246.03MM $225.69MM
Assets $331.57MM $270.31MM $252.15MM
Operating Cash Flow $-46.57MM $-63.76MM $-55.66MM
Capital expenditure $1.35MM $7.98MM $0.96MM
Investing Cash Flow $-143.58MM $-1.37MM $-50.55MM
Financing Cash Flow $2.02MM $0.96MM $35.58MM
Earnings Per Share* $-1.28 $-1.61 $-1.44

* EPS are Split Adjusted, recent splits may be reflected with a delay.